The Janssen Infectious Diseases & Vaccines multidisciplinary development team, including physicians, virologists, toxicologists, statisticians, data managers, experts in chemistry and pharmaceutics, regulatory experts and project managers among others, is dedicated to the rapid development of transformational medicines and vaccines.

Our unique approach to the discovery and development process means that we are capable of vigorously investigating multiple therapies in areas of high unmet need.

We are committed to developing innovative new medicines and we partner with the world’s leading experts, academic institutions, patient advocacy groups and other pharmaceutical companies to advance and improve treatments.

Our approach to fighting life-threatening diseases includes developing multiple mechanisms of action to block the effects of a virus.

To date, we have successfully developed approved treatments for HIV, hepatitis C and multi-drug-resistant tuberculosis (MDR-TB.)